Attached files
file | filename |
---|---|
EX-20.1 - IMMUNOTECH LABORATORIES GENERAL PLAN - Immunotech Laboratories, Inc. | ex-20_1.htm |
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
December 15, 2010
Date of Report (Date of earliest event reported)
IMMUNOTECH LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Nevada | 333-57514 | 95-4834274 | ||
(State or other jurisdiction | (Commission | (IRS Employer | ||
of incorporation) | File Number) | Identification Number) |
116 West Stocker Street, Glendale, California | 91202 | |
(Address of principal executive offices) | (Zip Code) |
(818) 409-9091
Registrants telephone number, including area code
International Technology Systems, Inc. 520 Broadway, Suite 350, PMB 188, Santa Monica, California 90401
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
9.01 Financial Statements and Exhibits | |
Signatures | |
EXHIBIT INDEX | |
EX-20.1 Immunotech Laboratories General Plan |
Table of Contents
Item 9.01. Financial Statements and Exhibits.
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IMMUNOTECH LABORATORIES, INC. |
|||||
Date: December 15, 2010 | By: | /s/ Ara Ghanime | |||
Ara Ghanime | |||||
President | |||||
Table of Contents
EXHIBIT INDEX
Exhibit Number | Description of Exhibit |
|
EX-20.1 |
Immunotech Laboratories General Plan |